Injunction Clears Early Threat To TAP's Lupron Depot
Generic drug maker QLT Inc. has been dealt yet another blow in its effort to maintain its presence in the market for prostate cancer treatments, with a federal judge issuing a...To view the full article, register now.
Already a subscriber? Click here to view full article